Abiopharma

REDHILL BIOPHARMA LTD. (RDHL) Files Form 6-K

OPKO Health’s ModeX Therapeutics Begins Clinical Trial of Tetraspecific Antibody for Treatment of B-cell Lymphomas

(30% Negative) INCANNEX HEALTHCARE INC. (IXHL) Announces Delay in Treatments Trials for Serious Mental Illness Due to Pandemic-Related Challenges, Regulatory Process, Safety Review

Corbus Pharmaceuticals Announces Abstracts Accepted for Presentation at ASCO 2026 Featuring Updated Clinical Data for CRB-701

McKesson Corporation - McKesson Corporation Declares Quarterly Dividend

New Form DEF 14A - Consolidated Water Co. Ltd. <b>Filed:</b> 2026-04-22 <b>AccNo:</b> 0001104659-26-046528 <b>Size:</b> 4 MB

(99% Neutral) SPECTRAL AI, INC. (MDAI) Announces Regulatory Update

(30% Negative) ORRSTOWN FINANCIAL SERVICES INC (ORRF) Reports Q2 2026 Financial Results

AGENCIA COMERCIAL SPIRITS LTD. (AGCC) Files Form 6-K

(10% Negative) TENAX THERAPEUTICS, INC. (TENX) Announces Delay in roles Trials for Tenax’s evolution Due to Geopolitical Situation, Pandemic-Related Challenges, Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations

CBL INTERNATIONAL LTD (BANL) Files Form 6-K

AAR and Woodward sign multi-year commercial distribution agreement

IP Strategy Highlights the Story Global Wallet: Advancing Access to Programmable IP Infrastructure

OPKO Health’s ModeX Therapeutics Begins Clinical Trial of Tetraspecific Antibody for Treatment of B-cell Lymphomas

Enphase Energy Expands VPP Capabilities in Australia with Evergen